Key Takeaways Doctors do not advise using GLP-1 medications in pregnancy because they might harm the baby
By this stage, the people who will respond to tirzepatide have responded
Semaglutide as a bridge to next-generation multireceptor agonists The success of semaglutide has transformed the therapeutic landscape for obesity and T2D, providing a conceptual foundation for developing next-generation incretin coagonists
CenterWell pharmacys partnership with Novo Nordisk is directed at cash-paying consumers, or what the industry calls self-pay patients, who dont have health insurance coverage for anti-obesity drugs, which are dropping in price but even with discounts cost several hundred dollars an injection
However, never use a microwave or hot water to warm it up, as heat can damage the proteins in the medication
The GIC responded with plans to raise deductibles and copays and eliminate coverage for GLP-1 medications unless the drugs were prescribed for more than weight management